| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Absci Corp | Chief Innovation Officer | Common Stock | 324,172 | $1,192,952 | $3.68 | 14 Oct 2025 | Direct |
| Cyclerion Therapeutics, Inc. | Chief Scientific Officer | Employee Stock Option (Right to Buy) | 135,000 | 20 Jan 2022 | Direct | ||
| Absci Corp | Chief Innovation Officer | Stock Option (right to buy) | 93,700 | 03 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABSI | Absci Corp | 14 Oct 2025 | 1 | -$11,379 | 4 | Chief Innovation Officer | 14 Oct 2025, 16:50 |
| ABSI | Absci Corp | 28 Jul 2025 | 1 | +$152,000 | 4 | Chief Innovation Officer | 29 Jul 2025, 08:37 |
| ABSI | Absci Corp | 03 Mar 2025 | 2 | $0 | 4 | Chief Innovation Officer | 04 Mar 2025, 17:40 |
| ABSI | Absci Corp | 01 Feb 2025 | 1 | -$5,450 | 4 | Chief Innovation Officer | 04 Feb 2025, 16:30 |
| ABSI | Absci Corp | 12 Oct 2024 | 1 | -$12,584 | 4 | Chief Innovation Officer | 16 Oct 2024, 17:59 |
| ABSI | Absci Corp | 01 Feb 2024 | 2 | $0 | 4 | Chief Innovation Officer | 05 Feb 2024, 19:14 |
| ABSI | Absci Corp | 12 Oct 2023 | 1 | $0 | 4 | Chief Innovation Officer | 16 Oct 2023, 18:11 |
| ABSI | Absci Corp | 01 Mar 2023 | 1 | $0 | 4 | Chief Innovation Officer | 03 Mar 2023, 16:41 |
| ABSI | Absci Corp | 03 Oct 2022 | 1 | $0 | 4 | Chief Innovation Officer | 05 Oct 2022, 20:31 |
| ABSI | Absci Corp | 08 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 16:52 |
| ABSI | Absci Corp | 17 Mar 2022 | 1 | $0 | 4 | Director | 21 Mar 2022, 18:00 |
| ABSI | Absci Corp | 17 Mar 2022 | 0 | $0 | 3 | Director | 21 Mar 2022, 17:58 |
| CYCN | Cyclerion Therapeutics, Inc. | 20 Jan 2022 | 1 | $0 | 4 | Chief Scientific Officer | 24 Jan 2022, 10:48 |
| CYCN | Cyclerion Therapeutics, Inc. | 09 Dec 2021 | 1 | $0 | 4 | Chief Scientific Officer | 10 Dec 2021, 15:32 |